EGFR c.1391C>T ;(p.S464L)

Variant ID: 7-55227924-C-T

NM_005228.3(EGFR):c.1391C>T;(p.S464L)

This variant was identified in 42 publications

View GRCh38 version.




Publications:


Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer.

Cancer Discovery
Pradat, Yoann Y; Viot, Julien J; Yurchenko, Andrey A AA; Gunbin, Konstantin K; Cerbone, Luigi L; Deloger, Marc M; Grisay, Guillaume G; Verlingue, Loic L; Scott, Veronique V; Padioleau, Ismael I; Panunzi, Leonardo L; Michiels, Stefan S; Hollebecque, Antoine A; Jules-Clement, Gerome G; Mezquita, Laura L; Laine, Antoine A; Loriot, Yohann Y; Besse, Benjamin B; Friboulet, Luc L; Andre, Fabrice F; Cournede, Paul-Henry PH; Gautheret, Daniel D; Nikolaev, Sergey I SI
Publication Date: 2023-03-02

Variant appearance in text: EGFR: 1391C>T; Ser464Leu
PubMed Link: 36862804
Variant Present in the following documents:
  • cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 10
  • cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 6
View BVdb publication page



Engaging innate immunity for targeting the epidermal growth factor receptor: Therapeutic options leveraging innate immunity versus adaptive immunity versus inhibition of signaling.

Frontiers In Oncology
Hintzen, Gabriele G; Dulat, Holger J HJ; Rajkovic, Erich E
Publication Date: 2022

Variant appearance in text: EGFR: S464L
PubMed Link: 36185288
Variant Present in the following documents:
  • Main text
  • fonc-12-892212.pdf
View BVdb publication page



Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer.

Frontiers In Oncology
Yu, Haipeng H; Xu, Yan Y; Gao, Wei W; Li, Mei M; He, Ji'an J; Deng, Xiaoqian X; Xing, Wenge W
Publication Date: 2022

Variant appearance in text: EGFR: S464L
PubMed Link: 36072793
Variant Present in the following documents:
  • Table_3.xlsx, sheet 1
View BVdb publication page



Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance.

Nature Communications
Zhuang, Xinlei X; Wang, Zhe Z; Fan, Jiansheng J; Bai, Xuefei X; Xu, Yingchun Y; Chou, James J JJ; Hou, Tingjun T; Chen, Shuqing S; Pan, Liqiang L
Publication Date: 2022-07-30

Variant appearance in text: EGFR: S464L
PubMed Link: 35907884
Variant Present in the following documents:
  • Main text
  • 41467_2022_32159_MOESM2_ESM.pdf
  • 41467_2022_Article_32159.pdf
  • 41467_2022_32159_MOESM1_ESM.pdf
View BVdb publication page



AACR Project GENIE: 100,000 Cases and Beyond.

Cancer Discovery
Pugh, Trevor J TJ; Bell, Jonathan L JL; Bruce, Jeff P JP; Doherty, Gary J GJ; Galvin, Matthew M; Green, Michelle F MF; Hunter-Zinck, Haley H; Kumari, Priti P; Lenoue-Newton, Michele L ML; Li, Marilyn M MM; Lindsay, James J; Mazor, Tali T; Ovalle, Andrea A; Sammut, Stephen-John SJ; Schultz, Nikolaus N; Yu, Thomas V TV; Sweeney, Shawn M SM; Bernard, Brady B; ,
Publication Date: 2022-09-02

Variant appearance in text: EGFR: S464L
PubMed Link: 35819403
Variant Present in the following documents:
  • cd-21-1547_supplementary_table_1_suppst1.xlsx, sheet 1
View BVdb publication page



Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue.

Frontiers In Oncology
Loria, Rossella R; Vici, Patrizia P; Di Lisa, Francesca Sofia FS; Soddu, Silvia S; Maugeri-Saccà, Marcello M; Bon, Giulia G
Publication Date: 2022

Variant appearance in text: EGFR: S464L
PubMed Link: 35814399
Variant Present in the following documents:
  • Main text
  • fonc-12-877380.pdf
View BVdb publication page



Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test.

Cells
Vasseur, Damien D; Sassi, Hela H; Bayle, Arnaud A; Tagliamento, Marco M; Besse, Benjamin B; Marzac, Christophe C; Arbab, Ahmadreza A; Auger, Nathalie N; Cotteret, Sophie S; Aldea, Mihaela M; Blanc-Durand, Félix F; Géraud, Arthur A; Gazzah, Anas A; Loriot, Yohann Y; Hollebecque, Antoine A; Martín-Romano, Patricia P; Ngo-Camus, Maud M; Nicotra, Claudio C; Ponce, Santiago S; Sakkal, Madona M; Caron, Olivier O; Smolenschi, Cristina C; Micol, Jean-Baptiste JB; Italiano, Antoine A; Rouleau, Etienne E; Lacroix, Ludovic L
Publication Date: 2022-06-11

Variant appearance in text: EGFR: Ser464Leu
PubMed Link: 35741030
Variant Present in the following documents:
  • Main text
  • cells-11-01901.pdf
View BVdb publication page



Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05

Variant appearance in text: EGFR: S464L
PubMed Link: 35229492
Variant Present in the following documents:
  • PCMR-35-369-s003.xlsx, sheet 12
View BVdb publication page



The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer
Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J
Publication Date: 2022-02

Variant appearance in text: EGFR: Ser464Leu
PubMed Link: 35221333
Variant Present in the following documents:
  • 43018_2022_332_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: EGFR: S464L
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives.

Journal Of Cancer Metastasis And Treatment
Battaglin, Francesca F; Puccini, Alberto A; Naseem, Madiha M; Schirripa, Marta M; Berger, Martin D MD; Tokunaga, Ryuma R; McSkane, Michelle M; Khoukaz, Taline T; Soni, Shivani S; Zhang, Wu W; Lenz, Heinz-Josef HJ
Publication Date: 2018

Variant appearance in text: EGFR: S464L
PubMed Link: 34532592
Variant Present in the following documents:
  • Main text
  • nihms-1595780.pdf
View BVdb publication page



Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers.

Scientific Reports
Gilson, Pauline P; Saurel, Chloé C; Salleron, Julia J; Husson, Marie M; Demange, Jessica J; Merlin, Jean-Louis JL; Harlé, Alexandre A
Publication Date: 2021-05-18

Variant appearance in text: EGFR: 1391C>T; Ser464Leu
PubMed Link: 34006948
Variant Present in the following documents:
  • 41598_2021_90091_MOESM2_ESM.pdf
View BVdb publication page



Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope.

Scientific Reports
Makabe, Koki K; Yokoyama, Takeshi T; Uehara, Shiro S; Uchikubo-Kamo, Tomomi T; Shirouzu, Mikako M; Kimura, Kouki K; Tsumoto, Kouhei K; Asano, Ryutaro R; Tanaka, Yoshikazu Y; Kumagai, Izumi I
Publication Date: 2021-03-11

Variant appearance in text: EGFR: S464L
PubMed Link: 33707468
Variant Present in the following documents:
  • Main text
  • 41598_2021_Article_84171.pdf
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: EGFR: 1391C>T; S464L
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Tyrosine Kinase Receptors in Oncology.

International Journal Of Molecular Sciences
Esteban-Villarrubia, Jorge J; Soto-Castillo, Juan José JJ; Pozas, Javier J; San Román-Gil, María M; Orejana-Martín, Inmaculada I; Torres-Jiménez, Javier J; Carrato, Alfredo A; Alonso-Gordoa, Teresa T; Molina-Cerrillo, Javier J
Publication Date: 2020-11-12

Variant appearance in text: EGFR: S464L
PubMed Link: 33198314
Variant Present in the following documents:
  • Main text
  • ijms-21-08529.pdf
View BVdb publication page



Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy.

Cancer Biology & Therapy
Price, Timothy T; Ang, Agnes A; Boedigheimer, Michael M; Kim, Tae Won TW; Li, Jin J; Cascinu, Stefano S; Ruff, Paul P; Satya Suresh, Attili A; Thomas, Anne A; Tjulandin, Sergei S; Peeters, Marc M
Publication Date: 2020-10-02

Variant appearance in text: EGFR: S464L
PubMed Link: 33026965
Variant Present in the following documents:
  • Main text
  • KCBT_21_1798695.pdf
View BVdb publication page



ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib.

Translational Lung Cancer Research
Romero, Atocha A; Serna-Blasco, Roberto R; Alfaro, Cristina C; Sánchez-Herrero, Estela E; Barquín, Miguel M; Turpin, María Carmen MC; Chico, Sofía S; Sanz-Moreno, Sandra S; Rodrigez-Festa, Alejandro A; Laza-Briviesca, Raquel R; Cruz-Bermudez, Alberto A; Calvo, Virginia V; Royuela, Ana A; Provencio, Mariano M
Publication Date: 2020-06

Variant appearance in text: EGFR: S464L
PubMed Link: 32676317
Variant Present in the following documents:
  • Main text
  • tlcr-09-03-532.pdf
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: EGFR: S464L
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



Pan-cancer whole-genome analyses of metastatic solid tumours.

Nature
Priestley, Peter P; Baber, Jonathan J; Lolkema, Martijn P MP; Steeghs, Neeltje N; de Bruijn, Ewart E; Shale, Charles C; Duyvesteyn, Korneel K; Haidari, Susan S; van Hoeck, Arne A; Onstenk, Wendy W; Roepman, Paul P; Voda, Mircea M; Bloemendal, Haiko J HJ; Tjan-Heijnen, Vivianne C G VCG; van Herpen, Carla M L CML; Labots, Mariette M; Witteveen, Petronella O PO; Smit, Egbert F EF; Sleijfer, Stefan S; Voest, Emile E EE; Cuppen, Edwin E
Publication Date: 2019-11

Variant appearance in text: EGFR: Ser464Leu
PubMed Link: 31645765
Variant Present in the following documents:
  • 41586_2019_1689_MOESM10_ESM.xlsx, sheet 1
  • 41586_2019_1689_MOESM14_ESM.xlsx, sheet 1
View BVdb publication page



Immune Resistance and EGFR Antagonists in Colorectal Cancer.

Cancers
Giordano, Guido G; Remo, Andrea A; Porras, Almudena A; Pancione, Massimo M
Publication Date: 2019-07-31

Variant appearance in text: EGFR: S464L
PubMed Link: 31370270
Variant Present in the following documents:
  • Main text
  • cancers-11-01089.pdf
View BVdb publication page



RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer.

Molecular Oncology
van Helden, Erik J EJ; Angus, Lindsay L; Menke-van der Houven van Oordt, C Willemien CW; Heideman, Daniëlle A M DAM; Boon, Eline E; van Es, Suzanne C SC; Radema, Sandra A SA; van Herpen, Carla M L CML; de Groot, Derk Jan A DJA; de Vries, Elisabeth G E EGE; Jansen, Maurice P H M MPHM; Sleijfer, Stefan S; Verheul, Henk M W HMW
Publication Date: 2019-11

Variant appearance in text: EGFR: S464L
PubMed Link: 31350822
Variant Present in the following documents:
  • MOL2-13-2361-s007.xlsx, sheet 1
View BVdb publication page



IKKα Kinase Regulates the DNA Damage Response and Drives Chemo-resistance in Cancer.

Molecular Cell
Colomer, Carlota C; Margalef, Pol P; Villanueva, Alberto A; Vert, Anna A; Pecharroman, Irene I; Solé, Laura L; González-Farré, Mónica M; Alonso, Josune J; Montagut, Clara C; Martinez-Iniesta, Maria M; Bertran, Joan J; Borràs, Eva E; Iglesias, Mar M; Sabidó, Eduard E; Bigas, Anna A; Boulton, Simon J SJ; Espinosa, Lluís L
Publication Date: 2019-08-22

Variant appearance in text: EGFR: S464L
PubMed Link: 31302002
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer.

Cancer Cell
Woolston, Andrew A; Khan, Khurum K; Spain, Georgia G; Barber, Louise J LJ; Griffiths, Beatrice B; Gonzalez-Exposito, Reyes R; Hornsteiner, Lisa L; Punta, Marco M; Patil, Yatish Y; Newey, Alice A; Mansukhani, Sonia S; Davies, Matthew N MN; Furness, Andrew A; Sclafani, Francesco F; Peckitt, Clare C; Jiménez, Mirta M; Kouvelakis, Kyriakos K; Ranftl, Romana R; Begum, Ruwaida R; Rana, Isma I; Thomas, Janet J; Bryant, Annette A; Quezada, Sergio S; Wotherspoon, Andrew A; Khan, Nasir N; Fotiadis, Nikolaos N; Marafioti, Teresa T; Powles, Thomas T; Lise, Stefano S; Calvo, Fernando F; Guettler, Sebastian S; von Loga, Katharina K; Rao, Sheela S; Watkins, David D; Starling, Naureen N; Chau, Ian I; Sadanandam, Anguraj A; Cunningham, David D; Gerlinger, Marco M
Publication Date: 2019-07-08

Variant appearance in text: EGFR: S464L
PubMed Link: 31287991
Variant Present in the following documents:
  • mmc6.xlsx, sheet 4
View BVdb publication page



Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort.

Frontiers In Oncology
Lee, Jeeyun J; Franovic, Aleksandra A; Shiotsu, Yukimasa Y; Kim, Seung Tae ST; Kim, Kyoung-Mee KM; Banks, Kimberly C KC; Raymond, Victoria M VM; Lanman, Richard B RB
Publication Date: 2019

Variant appearance in text: EGFR: S464L
PubMed Link: 31019892
Variant Present in the following documents:
  • Main text
  • fonc-09-00212.pdf
View BVdb publication page



Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC).

Frontiers In Oncology
El-Deiry, Wafik S WS; Winer, Arthur A; Slifker, Michael M; Taylor, Stanford S; Adamson, Blythe J S BJS; Meropol, Neal J NJ; Ross, Eric A EA
Publication Date: 2019

Variant appearance in text: EGFR: S464L
PubMed Link: 30923702
Variant Present in the following documents:
  • Data_Sheet_2.xlsx, sheet 1
View BVdb publication page



Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Cho, Sung-Yup SY; Chae, Jeesoo J; Na, Deukchae D; Kang, Wonyoung W; Lee, Ahra A; Min, Seoyeon S; Kang, Jinjoo J; Choi, Boram B; Lee, Jieun J; Sung, Chang Ohk CO; Chuang, Jeffrey H JH; Lee, Charles C; Lee, Won-Suk WS; Park, Hansoo H; Kim, Jong-Il JI
Publication Date: 2019-05-01

Variant appearance in text: EGFR: S464L
PubMed Link: 30670495
Variant Present in the following documents:
  • Main text
View BVdb publication page



Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer.

Frontiers In Oncology
Jia, Jingquan J; Morse, Michael A MA; Nagy, Rebecca J RJ; Lanman, Richard B RB; Strickler, John H JH
Publication Date: 2018

Variant appearance in text: EGFR: S464L
PubMed Link: 30211110
Variant Present in the following documents:
  • Main text
  • fonc-08-00305.pdf
View BVdb publication page



Integrative omics analyses broaden treatment targets in human cancer.

Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Publication Date: 2018-07-27

Variant appearance in text: EGFR: S464L
PubMed Link: 30053901
Variant Present in the following documents:
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 3
View BVdb publication page



Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer.

The Oncologist
Nakamura, Yoshiaki Y; Yoshino, Takayuki T
Publication Date: 2018-11

Variant appearance in text: EGFR: S464L
PubMed Link: 29700206
Variant Present in the following documents:
  • Main text
View BVdb publication page



Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.

Jama Oncology
Montagut, Clara C; Argilés, Guillem G; Ciardiello, Fortunato F; Poulsen, Thomas T TT; Dienstmann, Rodrigo R; Kragh, Michael M; Kopetz, Scott S; Lindsted, Trine T; Ding, Cliff C; Vidal, Joana J; Clausell-Tormos, Jenifer J; Siravegna, Giulia G; Sánchez-Martín, Francisco J FJ; Koefoed, Klaus K; Pedersen, Mikkel W MW; Grandal, Michael M MM; Dvorkin, Mikhail M; Wyrwicz, Lucjan L; Rovira, Ana A; Cubillo, Antonio A; Salazar, Ramon R; Desseigne, Françoise F; Nadal, Cristina C; Albanell, Joan J; Zagonel, Vittorina V; Siena, Salvatore S; Fumi, Guglielmo G; Rospo, Giuseppe G; Nadler, Paul P; Horak, Ivan D ID; Bardelli, Alberto A; Tabernero, Josep J
Publication Date: 2018-04-12

Variant appearance in text: EGFR: S464L
PubMed Link: 29423521
Variant Present in the following documents:
  • Main text
View BVdb publication page



Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Schrock, Alexa B AB; Pavlick, Dean D; Klempner, Samuel J SJ; Chung, Jon H JH; Forcier, Brady B; Welsh, Allison A; Young, Lauren L; Leyland-Jones, Bryan B; Bordoni, Rodolfo R; Carvajal, Richard D RD; Chao, Joseph J; Kurzrock, Razelle R; Sicklick, Jason K JK; Ross, Jeffrey S JS; Stephens, Philip J PJ; Devoe, Craig C; Braiteh, Fadi F; Ali, Siraj M SM; Miller, Vincent A VA
Publication Date: 2018-04-15

Variant appearance in text: EGFR: S464L
PubMed Link: 29363525
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations.

Genome Research
Brammeld, Jonathan S JS; Petljak, Mia M; Martincorena, Inigo I; Williams, Steven P SP; Alonso, Luz Garcia LG; Dalmases, Alba A; Bellosillo, Beatriz B; Robles-Espinoza, Carla Daniela CD; Price, Stacey S; Barthorpe, Syd S; Tarpey, Patrick P; Alifrangis, Constantine C; Bignell, Graham G; Vidal, Joana J; Young, Jamie J; Stebbings, Lucy L; Beal, Kathryn K; Stratton, Michael R MR; Saez-Rodriguez, Julio J; Garnett, Mathew M; Montagut, Clara C; Iorio, Francesco F; McDermott, Ultan U
Publication Date: 2017-04

Variant appearance in text: EGFR: S464L
PubMed Link: 28179366
Variant Present in the following documents:
  • supp_gr.213546.116_Supplemental_Table_S1.xlsx, sheet 1
View BVdb publication page



Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.

Nature Communications
Van Emburgh, Beth O BO; Arena, Sabrina S; Siravegna, Giulia G; Lazzari, Luca L; Crisafulli, Giovanni G; Corti, Giorgio G; Mussolin, Benedetta B; Baldi, Federica F; Buscarino, Michela M; Bartolini, Alice A; Valtorta, Emanuele E; Vidal, Joana J; Bellosillo, Beatriz B; Germano, Giovanni G; Pietrantonio, Filippo F; Ponzetti, Agostino A; Albanell, Joan J; Siena, Salvatore S; Sartore-Bianchi, Andrea A; Di Nicolantonio, Federica F; Montagut, Clara C; Bardelli, Alberto A
Publication Date: 2016-12-08

Variant appearance in text: EGFR: S464L
PubMed Link: 27929064
Variant Present in the following documents:
  • ncomms13665.pdf
  • ncomms13665-s1.pdf
View BVdb publication page



The Panitumumab EGFR Complex Reveals a Binding Mechanism That Overcomes Cetuximab Induced Resistance.

Plos One
Sickmier, E Allen EA; Kurzeja, Robert J M RJ; Michelsen, Klaus K; Vazir, Mukta M; Yang, Evelyn E; Tasker, Andrew S AS
Publication Date: 2016

Variant appearance in text: EGFR: S464L
PubMed Link: 27658254
Variant Present in the following documents:
  • Main text
  • pone.0163366.pdf
View BVdb publication page



Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer.

World Journal Of Gastroenterology
Sforza, Vincenzo V; Martinelli, Erika E; Ciardiello, Fortunato F; Gambardella, Valentina V; Napolitano, Stefania S; Martini, Giulia G; Della Corte, Carminia C; Cardone, Claudia C; Ferrara, Marianna L ML; Reginelli, Alfonso A; Liguori, Giuseppina G; Belli, Giulio G; Troiani, Teresa T
Publication Date: 2016-07-28

Variant appearance in text: EGFR: S464L
PubMed Link: 27605871
Variant Present in the following documents:
  • Main text
View BVdb publication page



Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.

Oncotarget
Braig, Friederike F; Voigtlaender, Minna M; Schieferdecker, Aneta A; Busch, Chia-Jung CJ; Laban, Simon S; Grob, Tobias T; Kriegs, Malte M; Knecht, Rainald R; Bokemeyer, Carsten C; Binder, Mascha M
Publication Date: 2016-07-12

Variant appearance in text: EGFR: S464L
PubMed Link: 27119512
Variant Present in the following documents:
  • Main text
  • oncotarget-07-42988.pdf
View BVdb publication page



Colorectal cancer: Overcoming resistance to anti-EGFR therapy - where do we stand?

Nature Reviews. Gastroenterology & Hepatology
Schirripa, Marta M; Lenz, Heinz-Josef HJ
Publication Date: 2016-05

Variant appearance in text: EGFR: Ser464Leu
PubMed Link: 27006256
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma.

Bmc Cancer
Kim, Eun Young EY; Cho, Eun Na EN; Park, Heae Surng HS; Kim, Arum A; Hong, Ji Young JY; Lim, Seri S; Youn, Jong Pil JP; Hwang, Seung Yong SY; Chang, Yoon Soo YS
Publication Date: 2016-01-18

Variant appearance in text: EGFR: 1391C>T
PubMed Link: 26782967
Variant Present in the following documents:
  • 12885_2016_2049_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer.

Oncotargets And Therapy
Patel, Shiven B SB; Gill, David D; Garrido-Laguna, Ignacio I
Publication Date: 2016

Variant appearance in text: EGFR: S464L
PubMed Link: 26770060
Variant Present in the following documents:
  • Main text
  • ott-9-075.pdf
View BVdb publication page



Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.

Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
Publication Date: 2015-09-24

Variant appearance in text: EGFR: S464L
PubMed Link: 26388441
Variant Present in the following documents:
  • mmc4.xlsx, sheet 1
View BVdb publication page



Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers.

British Journal Of Cancer
Khelwatty, Said A SA; Essapen, Sharadah S; Seddon, Alan M AM; Fan, Zhen Z; Modjtahedi, Helmout H
Publication Date: 2015-09-29

Variant appearance in text: EGFR: S464L
PubMed Link: 26372697
Variant Present in the following documents:
  • Main text
  • bjc2015319a.pdf
View BVdb publication page